CAS Investment Partners LLC acquired a new position in shares of Herbalife Ltd. (NYSE:HLF) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 565,241 shares of the company’s stock, valued at approximately $38,278,000. Herbalife comprises 21.1% of CAS Investment Partners LLC’s investment portfolio, making the stock its 2nd biggest holding.
A number of other hedge funds have also bought and sold shares of the business. Renaissance Technologies LLC increased its holdings in Herbalife by 22.9% during the 4th quarter. Renaissance Technologies LLC now owns 448,100 shares of the company’s stock worth $30,345,000 after purchasing an additional 83,500 shares during the last quarter. University of Notre Dame DU Lac increased its holdings in Herbalife by 44.2% during the 4th quarter. University of Notre Dame DU Lac now owns 109,930 shares of the company’s stock worth $7,444,000 after purchasing an additional 33,714 shares during the last quarter. Alliancebernstein L.P. increased its holdings in Herbalife by 4.8% during the 4th quarter. Alliancebernstein L.P. now owns 41,803 shares of the company’s stock worth $2,831,000 after purchasing an additional 1,920 shares during the last quarter. Leucadia National Corp increased its holdings in Herbalife by 17.3% during the 4th quarter. Leucadia National Corp now owns 13,889 shares of the company’s stock worth $940,000 after purchasing an additional 2,049 shares during the last quarter. Finally, Burney Co. bought a new stake in shares of Herbalife in the 4th quarter valued at approximately $293,000. Institutional investors own 98.92% of the company’s stock.
HLF has been the subject of a number of research analyst reports. SunTrust Banks reiterated a “hold” rating and issued a $67.00 price target on shares of Herbalife in a report on Friday, November 10th. ValuEngine upgraded Herbalife from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 22nd. Zacks Investment Research upgraded Herbalife from a “strong sell” rating to a “hold” rating in a report on Wednesday, January 3rd. Pivotal Research reiterated a “buy” rating and issued a $120.00 price target on shares of Herbalife in a report on Thursday, January 25th. Finally, Citigroup reiterated a “neutral” rating and issued a $85.00 price target (up from $73.00) on shares of Herbalife in a report on Thursday, February 22nd. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $97.60.
Shares of Herbalife Ltd. (HLF) opened at $96.84 on Wednesday. Herbalife Ltd. has a twelve month low of $50.70 and a twelve month high of $97.09. The company has a debt-to-equity ratio of -6.47, a current ratio of 2.05 and a quick ratio of 1.68. The firm has a market capitalization of $8,241.05, a P/E ratio of 19.40 and a beta of 1.20.
Herbalife (NYSE:HLF) last issued its quarterly earnings results on Thursday, February 22nd. The company reported $1.29 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.96 by $0.33. The business had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.08 billion. Herbalife had a return on equity of 457.78% and a net margin of 4.83%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.00 EPS. sell-side analysts predict that Herbalife Ltd. will post 5.3 earnings per share for the current fiscal year.
In related news, SVP Ibelis Montesino sold 16,219 shares of the company’s stock in a transaction on Tuesday, March 6th. The stock was sold at an average price of $93.84, for a total transaction of $1,521,990.96. Following the completion of the transaction, the senior vice president now directly owns 32,177 shares in the company, valued at approximately $3,019,489.68. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director John Tartol sold 2,297 shares of the company’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $92.10, for a total value of $211,553.70. Following the transaction, the director now owns 200,539 shares of the company’s stock, valued at $18,469,641.90. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 101,559 shares of company stock valued at $8,528,798. 4.95% of the stock is owned by company insiders.
Herbalife Company Profile
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. Its operating segments are based on geographical operations in six regions: North America; Mexico; South and Central America; Europe, the Middle East, and Africa (EMEA); Asia Pacific, and China.
Want to see what other hedge funds are holding HLF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Herbalife Ltd. (NYSE:HLF).